ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,565,000 | +78.2% | 20,400 | 0.0% | 0.01% | +66.7% |
Q3 2020 | $878,000 | -83.4% | 20,400 | -83.3% | 0.00% | -70.0% |
Q2 2020 | $5,278,000 | +50.9% | 122,200 | +0.5% | 0.01% | +11.1% |
Q1 2020 | $3,498,000 | -65.2% | 121,600 | -23.2% | 0.01% | -55.0% |
Q4 2019 | $10,048,000 | +1146.7% | 158,400 | +453.8% | 0.02% | +900.0% |
Q3 2019 | $806,000 | -43.5% | 28,600 | -63.2% | 0.00% | -66.7% |
Q1 2019 | $1,426,000 | +109.4% | 77,700 | +41.8% | 0.01% | +100.0% |
Q4 2018 | $681,000 | +0.6% | 54,800 | +55.2% | 0.00% | +50.0% |
Q3 2018 | $677,000 | +64.3% | 35,300 | +16.5% | 0.00% | 0.0% |
Q2 2018 | $412,000 | +172.8% | 30,300 | +44.3% | 0.00% | +100.0% |
Q1 2018 | $151,000 | +96.1% | 21,000 | 0.0% | 0.00% | – |
Q4 2017 | $77,000 | – | 21,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |